Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
drugs
4
×
fda
4
×
life sciences
national blog main
new york blog main
new york top stories
pfizer
4
×
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
investing
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
abbvie
astrazeneca
bristol-myers squibb
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
inflammatory bowel disease
microbiome
national
nonalcoholic steatohepatitis
pain drug
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
What
drug
bio
europe
fda
roundup
alnylam
alzheimer’s
annual
approved
approves
assessed
attention
babies
biotech
birth
born
breastfeed
cells
communities
companies
conference
days
digital
disease
ema
employ
epidemic
esmo
fatty
follows
frenzied
gene
germany
giving
growing
gut
harmful
hits
hosted
instructed
Language
Current search:
pfizer
×
drugs
×
fda
×
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
